Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and NanoKnife® systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.
AngioDynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the company’s consistent ability to successfully develop and bring to market new technologies and products. AngioDynamics believes it is well poised to continue that trend. Looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.

Latham, US
1,300 (est)
AngioDynamics is headquartered in Latham, US

AngioDynamics Locations

Latham, US

AngioDynamics Metrics

AngioDynamics Summary

Market capitalization

$614 M

Closing share price

AngioDynamics's current market capitalization is $614 M.

AngioDynamics Financials

AngioDynamics's revenue is $354 M in FY, 2016 which is 0.86% decrease from the previous period.
FY, 2014FY, 2015FY, 2016


$354 M$357 M$354 M

Gross profit

$180 M$177 M$174 M

Operating income

$13.4 M$-994 K$1.02 M

Operating expense total

$166 M$178 M$173 M

Net Income

$3.09 M$-3.27 M$-43.6 M

Operating cash flow

$-5.7 M$2.29 M$13.9 M

    AngioDynamics Market Value History

    AngioDynamics Online Presence

    AngioDynamics Company Life

    You may also be interested in